Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Cord Blood America CEO and Co-Founder Matthew Schissler Named Chairman of Biotech Committee for Nevada Development Authority

February 1, 2011

LAS VEGAS, Feb. 1, 2011 /PRNewswire/ — Cord Blood America, Inc. (OTC Bulletin Board: CBAI) (www.cordblood-america.com) has announced that Cord Blood America’s CEO and Co-Founder Matthew Schissler has been named chairman of the Biotech Committee for the Nevada Development Authority. The Biotech Committee is charged with developing programs and initiatives to help attract new biotech businesses to Southern Nevada and help existing biotech companies expand in the area.

“I am honored to be named chairman of the Biotech Committee for the Nevada Development Authority and look forward to working with the committee to help attract new biotech businesses and expand existing ones in Southern Nevada,” said Mr. Schissler.

He added, “Moving Cord Blood America to Southern Nevada 18 months ago was one of the best decisions in our history. Nevada is extremely business friendly through low tax rates, laws and regulations. Access to one of the busiest airports in the country, ease of getting around with little traffic or infrastructure issues, and the low cost of real estate and living were the key decision points for us. Couple those with world-class accommodations, entertainment, millions of people attending conventions, and more than 20 percent of the top 100-rated restaurants in the country being on The Strip, and you have a recipe for an unsurpassed business environment. I look forward to delivering this message to the thousands of domestic and international biotechs looking for a place to call home.”

Somer Hollingsworth, president and CEO of the NDA, said Mr. Schissler is an asset to the NDA and will serve as a strong ambassador for the biotech and related industries.

“Now more than ever is a crucial time in Nevada’s history to become increasingly proactive in attracting new businesses to our state,” Mr. Hollingsworth said. “The biotech sector is a natural fit for Nevada, and we are relishing the fact that companies like Cord Blood America are realizing the advantages Nevada has to offer and are stepping up efforts to be a voice for our state.”

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of diseases, including cancer, leukemia, blood and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit www.corcell.com. For investor information, visit www.cordblood-america.com.

About Nevada Development Authority

The Nevada Development Authority is a non-profit agency that works to diversify and improve the economy of Southern Nevada. Established in Las Vegas in 1956, the NDA is dedicated to fostering an attractive, business-friendly environment through building key relationships while assisting and targeting new and expanding businesses. The mission of the NDA is to attract, retain and expand the business base and enhance the overall socioeconomic development of Southern Nevada.


    CONTACT:
    Paul Knopick
    E & E Communications
    949/707-5365
    pknopick@eandecommunications.com

SOURCE Cord Blood America, Inc.


Source: newswire